Entering text into the input field will update the search result below

Allscripts -19.2% on Q3 miss, bookings drop

Nov. 07, 2014 9:01 AM ETVeradigm Inc. (MDRX) StockBy: Eric Jhonsa, SA News Editor
  • After growing 9% Y/Y in Q2, Allscripts' (NASDAQ:MDRX) bookings fell 5% Y/Y in Q3 to $223M. The company blames the drop on the fact 2013 bookings included "a significant agreement for expanded software, services and managed services with PIH Health." Excluding the deal, bookings were up 16%.
  • Nonetheless, on the CC (transcript), CEO Paul M. Black admitted Allscripts "would have liked to have delivered a stronger [bookings] performance," and that pricing is an issue. "It's -- not that there's a cut to our pricing, it's just the size of the deals are starting smaller and then you grow onto them from there."
  • Contracted backlog rose by $100M Q/Q to $3.4B. Gross margin fell 130 bps Y/Y to 42.3%, and GAAP opex fell 7% to $142.9M.
  • Evercore ISI has downgraded Allscripts to Hold, and cut its target to $12.50.
  • Q3 results, PR

Recommended For You

More Trending News

About MDRX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
MDRX--
Veradigm Inc.